<DOC>
	<DOCNO>NCT02784054</DOCNO>
	<brief_summary>The purpose study evaluate outcome intracranial non-germinomatous germ cell tumor ( NGGCT ) treat reduced radiotherapy follow high dose chemotherapy autologous stem cell transplantation ( HDCT/auto-SCT ) .</brief_summary>
	<brief_title>Reduced Dose Radiotherapy Following High Dose Chemotherapy Intracranial Non-germinomatous Germ Cell Tumor</brief_title>
	<detailed_description>Treatment outcome intracranial NGGCT around 50 % conventional chemo- radiotherapy . Also , late sequela endocrinopathy cognitive problem unavoidable especially craniospinal irradiation . In study , high dose chemotherapy reduce dose radiotherapy use improve survival minimize late sequela patient intracranial NGGCT .</detailed_description>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Patients pathologically prove intracranial nongerminomatous germ cell tumor Patients brain mass suspect intracranial germ cell tumor elevate serum cerebrospinal fluid alphafeto protein . Patients organ dysfunction ( ejection fraction &lt; 40 % , creatinine &gt; 3 x upper limit normal ( ULN ) , aspartate aminotransferase/alanine aminotransaminase &gt; 5 x ULN ) . Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>